Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Escitalopram in the treatment of patients with agitated dementia.

Trial Profile

Escitalopram in the treatment of patients with agitated dementia.

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Feb 2012

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Feb 2012 Actual end date (Dec 2006) added as reported by ClinicalTrials.gov.
    • 23 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top